Viemed Healthcare (NASDAQ:VMD) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Key Points

• Earnings miss: Viemed reported Q EPS of $0.06, missing the consensus by $0.03, though revenue of $75.41 million slightly beat expectations.
• Insider selling: Insiders sold 136,802 shares this quarter (including President Michael Moore's 65,000-share sale), totaling about $1.24 million, while insiders still own 20% of the stock.
• Market reaction and valuation: Shares traded up to $9.70 on the report; the company has a market cap of about $373 million, a P/E of 26.22, and a 52-week range of $5.93–$10.18.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) issued its earnings results on Tuesday. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03), FiscalAI reports. The firm had revenue of $75.41 million during the quarter, compared to analysts' expectations of $74.40 million. Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%.

Viemed Healthcare Price Performance

VMD stock traded up $0.22 during trading on Tuesday, reaching $9.70. 252,431 shares of the company were exchanged, compared to its average volume of 246,049. The company has a market cap of $373.26 million, a P/E ratio of 26.22 and a beta of 1.15. Viemed Healthcare has a 52-week low of $5.93 and a 52-week high of $10.18. The stock's 50 day moving average price is $9.31 and its 200 day moving average price is $7.94. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.06 and a current ratio of 1.18.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on VMD. Wall Street Zen raised shares of Viemed Healthcare from a "buy" rating to a "strong-buy" rating in a report on Saturday, February 14th. Zacks Research raised shares of Viemed Healthcare to a "hold" rating in a report on Thursday, January 8th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

Insider Buying and Selling

In related news, President Michael Moore sold 65,000 shares of the business's stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the sale, the president owned 1,585,812 shares of the company's stock, valued at approximately $13,907,571.24. The trade was a 3.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 136,802 shares of company stock worth $1,237,976 over the last quarter. 20.00% of the stock is currently owned by insiders.

Institutional Trading of Viemed Healthcare

A number of institutional investors have recently added to or reduced their stakes in VMD. Kemnay Advisory Services Inc. purchased a new stake in Viemed Healthcare during the fourth quarter worth about $46,000. Quarry LP purchased a new stake in Viemed Healthcare during the third quarter worth about $48,000. AQR Capital Management LLC purchased a new stake in Viemed Healthcare during the first quarter worth about $90,000. Invesco Ltd. boosted its holdings in Viemed Healthcare by 25.5% during the second quarter. Invesco Ltd. now owns 18,652 shares of the company's stock worth $129,000 after buying an additional 3,795 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in Viemed Healthcare by 52.7% during the fourth quarter. MetLife Investment Management LLC now owns 18,565 shares of the company's stock worth $138,000 after buying an additional 6,408 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company's stock.

About Viemed Healthcare

Viemed Healthcare, Inc NASDAQ: VMD is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.